Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs - PubMed (original) (raw)

. 2008 Feb 1:46 Suppl 2:S53-7.

doi: 10.1086/523342.

Affiliations

• PMID: 18181723
• DOI: 10.1086/523342

Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs

Freddie Ann Hoffman et al. Clin Infect Dis. 2008.

No abstract available

PubMed Disclaimer

Similar articles

• Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
  Mattia A, Merker R. Mattia A, et al. Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S115-8; discussion S144-51. doi: 10.1086/523329. Clin Infect Dis. 2008. PMID: 18181714
• Probiotic foods and drugs: impact of US regulatory status on design of clinical trials.
  Hibberd PL, Davidson L. Hibberd PL, et al. Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S137-40; discussion S144-51. doi: 10.1086/523321. Clin Infect Dis. 2008. PMID: 18181720
• Business considerations in the development of probiotics.
  Hoffman FA. Hoffman FA. Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S141-3; discussion S144-51. doi: 10.1086/523323. Clin Infect Dis. 2008. PMID: 18181721
• Probiotics in the United States.
  Vanderhoof JA, Young R. Vanderhoof JA, et al. Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S67-72; discussion S144-51. doi: 10.1086/523339. Clin Infect Dis. 2008. PMID: 18181726 Review.
• Allergen-free probiotics.
  Mogna G, Strozzi GP, Mogna L. Mogna G, et al. J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S201-4. doi: 10.1097/MCG.0b013e31818063ed. J Clin Gastroenterol. 2008. PMID: 18685500 Review.

Cited by

• Strain-specific genotyping of Bifidobacterium animalis subsp. lactis by using single-nucleotide polymorphisms, insertions, and deletions.
  Briczinski EP, Loquasto JR, Barrangou R, Dudley EG, Roberts AM, Roberts RF. Briczinski EP, et al. Appl Environ Microbiol. 2009 Dec;75(23):7501-8. doi: 10.1128/AEM.01430-09. Epub 2009 Oct 2. Appl Environ Microbiol. 2009. PMID: 19801460 Free PMC article.
• Probiotics as additives on therapy in allergic airway diseases: a systematic review of benefits and risks.
  Das RR, Naik SS, Singh M. Das RR, et al. Biomed Res Int. 2013;2013:231979. doi: 10.1155/2013/231979. Epub 2013 Jul 15. Biomed Res Int. 2013. PMID: 23956972 Free PMC article.
• Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats.
  Ricoldi MST, Furlaneto FAC, Oliveira LFF, Teixeira GC, Pischiotini JP, Moreira ALG, Ervolino E, de Oliveira MN, Bogsan CSB, Salvador SL, Messora MR. Ricoldi MST, et al. PLoS One. 2017 Jun 29;12(6):e0179946. doi: 10.1371/journal.pone.0179946. eCollection 2017. PLoS One. 2017. PMID: 28662142 Free PMC article.
• Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.
  Petrof EO. Petrof EO. Antiinflamm Antiallergy Agents Med Chem. 2009 Sep 1;8(3):260-269. doi: 10.2174/187152309789151977. Antiinflamm Antiallergy Agents Med Chem. 2009. PMID: 20890386 Free PMC article.
• Cell-bound Exopolysaccharide Extract from Indigenous Probiotic Bacteria Induce Apoptosis in HT-29 cell-line.
  Mojibi P, Tafvizi F, Bikhof Torbati M. Mojibi P, et al. Iran J Pathol. 2019 Winter;14(1):41-51. doi: 10.30699/IJP.14.1.41. Epub 2018 Dec 27. Iran J Pathol. 2019. PMID: 31531100 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems